Hartoun Hartounian

Calculated based on number of publications stored in Pure and citations from Scopus
1988 …2019

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

M. Patel

  • SkyePharma Inc.
  • Rutgers - The State University of New Jersey, New Brunswick
  • Sequenom, Inc.
  • Instrumentation Society of America
  • Sequenom Inc.
  • Rutgers University

External person

C. Pepper

  • SkyePharma Inc.
  • Washington State University Pullman
  • University of California at Los Angeles
  • DepoTech Corporation
  • ISPE
  • Proc. Development and Manufacturing
  • Amer. Inst. of Chemical Engineers

External person

S. I. Sandler

  • University of Delaware
  • Department of Chemical Engineering

External person

E. W. Kaler

  • University of Delaware
  • Department of Chemical Engineering

External person

David T. Allen

  • University of California at Los Angeles
  • Department of Chemical Engineering

External person

Jeremy M. Levin

  • Ovid Therapeutics

External person

Gerald F. Cox

  • Harvard University
  • Gerald Cox Rare Care Consulting
  • Boston Children's Hospital

External person

Gustav Christensen

  • Morphic Therapeutic
  • Morphic Therapeutic

External person

Ronald A. DePinho

  • University of Texas MD Anderson Cancer Center

External person

Gregory J. Flesher

  • Novus Therapeutics, Inc.

External person

David Bartel

  • Whitehead Institute for Biomedical Research
  • Howard Hughes Medical Institute

External person

Peter Barrett

  • Atlas Venture
  • Atlas Venture

External person

Jean Francois Formela

  • Atlas Venture
  • Atlas Venture

External person

Joshua Boger

  • Vertex Pharmaceuticals, Inc.

External person

Jim Bollenbacher

  • Bridgeway Search Group

External person

L. Patrick Gage

  • enGage Biotech Consulting

External person

Sally J. Curley

  • Curley Global IR (CGIR), LLC

External person

Douglas Doerfler

  • MaxCyte, Inc

External person

Cedric Francois

  • Apellis Pharmaceuticals

External person

Bruce Booth

  • Atlas Venture
  • Atlas Venture

External person

Ron Cohen

  • Acorda Therapeutics, Inc

External person

Jason Gardner

  • Magenta Therapeutics

External person

Deborah Dunsire

  • H. Lundbeck A/S

External person

Pavan Cheruvu

  • Axovant Sciences

External person

Michael P. Franken

  • TEQLA Therapeutics Inc.

External person

James E. Audia

  • Northwestern University

External person

Steven H. Holtzman

  • Decibel Therapeutics
  • Decibel Therapeutics, Inc.

External person

Wayne Eskridge

  • Fatty Liver Foundation

External person

Kenneth Fong

  • System Biosciences, Inc.

External person

John Diekman

  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures
  • 5AM Ventures

External person

Henry E. Chang

  • Hepatitis Business Solutions, LLC

External person

J. A. Koetitz

  • University of Delaware
  • Department of Chemical Engineering

External person

Jeff Albers

  • Blueprint Medicines
  • Blueprint Medical Corporation

External person

Yang Xin Fu

  • University of Texas Southwestern Medical Center

External person

Daniel Dornbusch

  • Excision BioTherapeutics

External person

Ricci, J.

  • DepoTech Corporation

External person

Richard H. Ebright

  • Rutgers - The State University of New Jersey, New Brunswick

External person

Charles L. Cooney

  • Massachusetts Institute of Technology

External person

Anne E. Carpenter

  • Broad Institute

External person

Heather Franklin

  • Blaze Bioscience, Inc.

External person

Richard H. Douglas

  • Aldeyra Therapeutics

External person

Michael P. Bailey

  • AVEO Oncology

External person

Phyllis Gardner

  • Stanford University

External person

Joseph E. Aoun

  • Northeastern University

External person

Olivier Brandicourt

  • Sanofi-Aventis

External person

E. Floeter

  • University of Delaware
  • Department of Chemical Engineering

External person

Kaye Foster-Cheek

  • Agios Pharmaceuticals

External person

George Church

  • Harvard University

External person

Mohamed Genead

  • AVICEDA Therapeutics LLC

External person

Robert I. Blum

  • Cytokenetics, Inc.

External person

Meissner, D.

  • DepoTech Corporation

External person

Michael D. Clayman

  • Flexion Therapeutics, Inc.
  • Flexion Therapeutics Inc.

External person

Michael W. Bonney

  • Magenta Therapeutics
  • Kaleido Biosciences Inc.

External person

Jean Jacques Bienamie

  • BioMarin Pharmaceutical Inc.

External person

Eugene Braunwald

  • Harvard University

External person

John Maraganore

  • Alnylam Pharmaceuticals

External person